TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Tumor deposit in the short gastric mesentery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Return to preinjury level of function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Western Ontario Shoulder Instability Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensor-based analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breastfeeding Session Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbiome diversity and composition changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response (CR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of a genetic cause
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: viability of human hepatocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cholesterol storage of human hepatocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: triglyceride storage of human hepatocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: oxidative stress status of human hepatocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pro-inflammatory cytokine expression of human hepatocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes of consciousness disorder after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in mean muscle volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in mean muscle fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intra bladder pressure during pushing efforts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: HPV Negativity Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Upper Extremity Fugl-Meyer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of Magnetic Resonance Cholangiopancreatography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Magnesium level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Wijma Birth Expectancy/Expectation Questionnaire (W-DEQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: VASA Pain Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wijma Birth Expectancy/Experience Scale B Version
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Saliva cortisol correlation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Saliva Alpha-amylase correlation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Parent-infant emotional availability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Days of treatment for persistent diarrhea symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Blood Insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: 30 second Sit-to-Stand Test (30STS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxford Elbow Score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with a new diagnosis of GU
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Digit Span (DGS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: cell density and numbers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cytokines detection-EpCAM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: cytokines detection-CD-45+ leukocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: counting of EpiCAM-positive and Hoechst-positive cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aortic mean gradient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Signal-to-background ratio (SBR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Penetration depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in COVID-19 vaccine perceptions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ecological Momentary Assessment (EMA) Adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: ELISPOT results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality-of-life survey responses
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Health-related quality of life of parents/caregivers
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of seizures as self-reported by participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of seizures as assessed by EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of seizures as assessed by the Percept PC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in six-minute walk distance (6 MWD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suicide ideation at three months after discharge
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of re-visits to outpatient clinic at three months after discharge
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Antiretroviral Therapy (ART) adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Increase (GMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adverse reaction incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Serious adverse events incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of Recovery (QoR)-15 score on postoperative day 1
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants with negative CTC count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-free Survival (PFS) Probability
Endpoint domain: Mortality/survival
Primary endpoint: occurrence rate of postoperative ileus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of VX-548 and its Metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve From the Time of Dosing Extrapolated to Infinity (AUC0-inf) of VX-548 and its Metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phenotype of Tregs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Anti-tissue transglutaminase (anti-tTG) antibodies IgA-IgG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total IGA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: PaO2 after 30 minutes of OLV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pelvic Floor Disability Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pelvic organ prolapse quantification (POP-Q)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CO2 measurement accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistence/resolution of dysfunctional breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Nrf2 activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in visual analogue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in pain pressure threshold (PPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily score on the Quality of Recovery-15 (QoR-15) scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Duration of diaper dermatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Diagnostic efficacy of 99mTc-FDPH46
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory infections incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Change in headaches
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evolution of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of adverse events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of serious adverse events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Tolerability after drug administration
Endpoint domain: Adverse events/effects
Primary endpoint: Area-under-the-effects curve for Product Liking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum product liking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Failure of Clindamycine
Endpoint domain: Adverse events/effects
Primary endpoint: Number of true positive cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Macular optical coherence tomography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postrotary Nystagmus Assessment Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensory Profile Test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Vanderbilt Assessment Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of men with clinically significant cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Identification of myocardial ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Methylation Level of PHGDH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-phosphoglycerate dehydrogenase (PHGDH) RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The clinical TCM scores of SKYD
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Confirmed malaria case incidence
Endpoint domain: Mortality/survival
Primary endpoint: Suicide Attempt
Endpoint domain: Adverse events/effects
Primary endpoint: Absolute values and changes in clinical laboratory parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absorbed dose coefficients in organs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of family carer satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Biochemically confirmed smoking abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child sleep (objective measurement)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability Status
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Multiple Sclerosis Impact
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pulse oximetry correlation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Boston Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median nerve area measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: LANNS neuropathic pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of occurrence of DLT
Endpoint domain: Adverse events/effects
Primary endpoint: Ability to recruit per treatment arm
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Comparison of immune cell population per treatment arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ulcer complete closure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: >2kg increase in body weight (office-based)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: >2 L increase in total body water
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: increase in 2 or more loop-diuretic equivalents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fluid retention adverse event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: FBAL (fluoro-beta-alanine) Excretion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: FBAL (fluoro-beta-alanine) Area under the Curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: FBAL (fluoro-beta-alanine) Clearance (CL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Docetaxel chemotherapy toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Functional assessment of Cancer therapy (FACT)-Taxane subscale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Manchester-Oxford Foot Questionnaire (MOXFQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Health Assessment Questionnaire [HAQ]
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: perceived anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Difference in mean Numerical Rating Scale (NRS) for pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with positive analgesic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of hair elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of hair gloss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of neutrophil elastase in the kidneys
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Task Specific Fears
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Overall Injury-Related Fear
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Active range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in parents' capability to support physical literacy development
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in parents' opportunity to support physical literacy development
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in parents' motivation to support physical literacy development
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Number of organ systems with HES signs and/or symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SAQ questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Differences in gut microbiome composition and function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Ultrasound abnormalities in septic hip arthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Neuropsychiatric Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Children's social problems
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Daily life executive functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Neonatal Chlamydia trachomatis or Neisseria gonorrhoeae infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: changes in air pressure (Tympanogram)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ear outcomes
Primary endpoint: Change in nuclear dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean score on the Decisional Conflict Scale (DCS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of participants with a total score of >37.5 on the DCS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Teen quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Teen celiac disease health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in symptoms of psoriasis as assessed by BSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in symptoms of psoriasis as assessed by Psoriasis Area Severity Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Quality of Life (QoL) of psoriasis patients
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of true penicillin allergies
Endpoint domain: Adverse events/effects
Primary endpoint: Change in prevalence rate of drug related problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: All-cause in-hospital mortality at 28 days
Endpoint domain: Mortality/survival
Primary endpoint: CRC screening rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: CRC ordering rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: CRC Completion rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pain relieving from Visual analogue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post patient anxiety scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes to the gut microbiota/microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in the plasma proteome/metabolome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Clinically and Radiologically Confirmed Anastomotic Leakage
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change in central macular thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraprocedural fresh thrombus formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence of new ischemic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Management of pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective response rate per RECIST 1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive flexibility function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: percentage of subjects who achieved target ACT (200-300 s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prognosis of sepsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Physical Well-Being Scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sensitivity of polydeep vs high experienced endoscopist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in frequency of self-injury thoughts and behaviours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in severity of suicidal ideation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Borderline Personality Symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Knowledge Scores on an 11-Point Likert (0-10) Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Self-Efficacy Scores on a 5-Point (1-5) Likert Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Intention Scores on a 5-Point (1-5) Likert Scale
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Vesicular Monoamine Transporter 2 Binding Potential (VAMT2 BPND)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Synaptic Vesicle Glycoprotein 2A Total Distribution Volume (SV2A VT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to improvement in cerebral edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prevalence of respiratory post-acute sequelae of SARS-CoV-2 (PASC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes